期刊
NON-CODING RNA RESEARCH
卷 7, 期 3, 页码 171-177出版社
KEAI PUBLISHING LTD
DOI: 10.1016/j.ncrna.2022.07.001
关键词
Brain tumors; Gliomas; microRNAs; Molecular markers; Therapeutic targets
This review examines the changes in micro-RNA expression profiles characteristic of gliomas, particularly in the context of glioblastoma (GBM). The functions of miRNAs in GBM pathways linked to dysregulation of cell cycle control, apoptosis, and resistance to treatment are summarized, along with the potential use of miRNAs as biomarkers in clinical settings.
Gliomas are invasive brain tumors characterized by high rates of recurrence and mortality. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogenicity and its resistance to the current treatment regimen. MicroRNA (miRNAs) are small non-coding sequences of RNA that regulate and influence the expression of multiple genes. The detection of certain types of micro-RNA in tissues and blood serum can be used for diagnosis and prognosis, including the response of a particular patient to therapy. The purpose of this review is to analyze studies and experimental results concerning changes in microRNA expression profiles characteristic of gliomas. Furthermore, miRNAs also contribute to autophagy at multiple stages. In this review, we summarize the func-tions of miRNAs in GBM pathways linked to dysregulation of cell cycle control, apoptosis and resistance to treatment, and the possible use of miRNAs in clinical settings as treatment and prediction biomarkers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据